These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16917729)

  • 1. TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.
    Maydan G; Andresen BS; Madsen PP; Zeigler M; Raas-Rothschild A; Zlotogorski A; Gutman A; Korman SH
    J Inherit Metab Dis; 2006 Oct; 29(5):620-6. PubMed ID: 16917729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.
    Bouyacoub Y; Zribi H; Azzouz H; Nasrallah F; Abdelaziz RB; Kacem M; Rekaya B; Messaoud O; Romdhane L; Charfeddine C; Bouziri M; Bouziri S; Tebib N; Mokni M; Kaabachi N; Boubaker S; Abdelhak S
    Gene; 2013 Oct; 529(1):45-9. PubMed ID: 23954227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.
    Charfeddine C; Monastiri K; Mokni M; Laadjimi A; Kaabachi N; Perin O; Nilges M; Kassar S; Keirallah M; Guediche MN; Kamoun MR; Tebib N; Ben Dridi MF; Boubaker S; Ben Osman A; Abdelhak S
    Mol Genet Metab; 2006 Jun; 88(2):184-91. PubMed ID: 16574453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II.
    Pasternack SM; Betz RC; Brandrup F; Gade EF; Clemmensen O; Lund AM; Christensen E; Bygum A
    Br J Dermatol; 2009 Mar; 160(3):704-6. PubMed ID: 18945316
    [No Abstract]   [Full Text] [Related]  

  • 5. A large TAT deletion in a tyrosinaemia type II patient.
    Legarda M; Wlodarczyk K; Lage S; Andrade F; Kim GJ; Bausch E; Scherer G; Aldamiz-Echevarria LJ
    Mol Genet Metab; 2011 Nov; 104(3):407-9. PubMed ID: 21636300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene.
    Culic V; Betz RC; Refke M; Fumic K; Pavelic J
    Eur J Med Genet; 2011; 54(3):205-8. PubMed ID: 21145993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation.
    Flusser H; Korman SH; Sato K; Matsubara Y; Galil A; Kure S
    Neurology; 2005 Apr; 64(8):1426-30. PubMed ID: 15851735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
    Hühn R; Stoermer H; Klingele B; Bausch E; Fois A; Farnetani M; Di Rocco M; Boué J; Kirk JM; Coleman R; Scherer G
    Hum Genet; 1998 Mar; 102(3):305-13. PubMed ID: 9544843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
    Peña-Quintana L; Scherer G; Curbelo-Estévez ML; Jiménez-Acosta F; Hartmann B; La Roche F; Meavilla-Olivas S; Pérez-Cerdá C; García-Segarra N; Giguère Y; Huppke P; Mitchell GA; Mönch E; Trump D; Vianey-Saban C; Trimble ER; Vitoria-Miñana I; Reyes-Suárez D; Ramírez-Lorenzo T; Tugores A
    Clin Genet; 2017 Sep; 92(3):306-317. PubMed ID: 28255985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.
    Natt E; Kida K; Odievre M; Di Rocco M; Scherer G
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9297-301. PubMed ID: 1357662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richner-Hanhart syndrome detected by expanded newborn screening.
    Meissner T; Betz RC; Pasternack SM; Eigelshoven S; Ruzicka T; Kruse R; Laitenberger G; Mayatepek E
    Pediatr Dermatol; 2008; 25(3):378-80. PubMed ID: 18577048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer.
    Boichard A; Venet L; Naas T; Boutron A; Chevret L; de Baulny HO; De Lonlay P; Legrand A; Nordman P; Brivet M
    Mol Genet Metab; 2008 Mar; 93(3):323-30. PubMed ID: 18023225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
    Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
    Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
    Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
    Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site.
    Otsuka H; Sasai H; Nakama M; Aoyama Y; Abdelkreem E; Ohnishi H; Konstantopoulou V; Sass JO; Fukao T
    Mol Med Rep; 2016 Nov; 14(5):4906-4910. PubMed ID: 27748876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene.
    Tran VK; Takeshima Y; Zhang Z; Yagi M; Nishiyama A; Habara Y; Matsuo M
    J Med Genet; 2006 Dec; 43(12):924-30. PubMed ID: 16738009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A G-to-T transversion at the splice acceptor site of dystrophin exon 14 shows multiple splicing outcomes that are not exemplified by transition mutations.
    Ota M; Takeshima Y; Nishida A; Awano H; Lee T; Yagi M; Matsuo M
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):3-8. PubMed ID: 21854195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation (c.121‑13T>A) in the polypyrimidine tract of the splice acceptor site of intron 2 causes exon 3 skipping in mitochondrial acetoacetyl-CoA thiolase gene.
    Aoyama Y; Sasai H; Abdelkreem E; Otsuka H; Nakama M; Kumar S; Aroor S; Shukla A; Fukao T
    Mol Med Rep; 2017 Jun; 15(6):3879-3884. PubMed ID: 28393214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6.
    Raponi M; Kralovicova J; Copson E; Divina P; Eccles D; Johnson P; Baralle D; Vorechovsky I
    Hum Mutat; 2011 Apr; 32(4):436-44. PubMed ID: 21309043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH.
    Duponchel C; Djenouhat K; Frémeaux-Bacchi V; Monnier N; Drouet C; Tosi M
    Hum Mutat; 2006 Mar; 27(3):295-6. PubMed ID: 16470590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.